Michael Henry Rosenbloom1, Alireza Atri. 1. Bedford VA Hospital, Geriatric Research and Education Clinical Center (GRECC), Bedford. Michael.H.Rosenbloom@HealthPartners.com
Abstract
BACKGROUND: Rapidly progressive dementia (RPD) is a unique set of disorders resulting in cognitive, behavioral, and motor decline within 2 years. A variety of etiologies may contribute to RPD including neurodegenerative, inflammatory, infectious, and toxic-metabolic conditions. Jakob-Creutzfeldt disease (CJD) is frequently the most concerning diagnosis on the differential. The challenge for the neurologist is distinguishing prion disease from reversible processes that result in dementia. REVIEW SUMMARY: This review discusses the clinical aspects and the diagnostic workup of RPD. Particular focus is given to both CJD and the potentially treatable inflammatory conditions that may cause a similar presentation. Furthermore, a standardized stepwise approach is outlined for patients presenting with RPD. CONCLUSIONS: Neurologists should adopt a standardized approach to the rapidly presenting disease processes that may mimic CJD in their clinical and radiologic features.
BACKGROUND: Rapidly progressive dementia (RPD) is a unique set of disorders resulting in cognitive, behavioral, and motor decline within 2 years. A variety of etiologies may contribute to RPD including neurodegenerative, inflammatory, infectious, and toxic-metabolic conditions. Jakob-Creutzfeldt disease (CJD) is frequently the most concerning diagnosis on the differential. The challenge for the neurologist is distinguishing prion disease from reversible processes that result in dementia. REVIEW SUMMARY: This review discusses the clinical aspects and the diagnostic workup of RPD. Particular focus is given to both CJD and the potentially treatable inflammatory conditions that may cause a similar presentation. Furthermore, a standardized stepwise approach is outlined for patients presenting with RPD. CONCLUSIONS: Neurologists should adopt a standardized approach to the rapidly presenting disease processes that may mimic CJD in their clinical and radiologic features.
Authors: K A Josephs; D S Knopman; J L Whitwell; B F Boeve; J E Parisi; R C Petersen; D W Dickson Journal: Neurology Date: 2005-08-23 Impact factor: 9.910
Authors: Klaus Zöphel; Bernhard Saller; Gerd Wunderlich; Thomas Grüning; Rainer Koch; Jürgen Wilde; Klaus Mann; Wolf-Gunter Franke Journal: Clin Lab Date: 2003 Impact factor: 1.138
Authors: Nicholas D Lawn; Barbara F Westmoreland; Michael J Kiely; Vanda A Lennon; Steven Vernino Journal: Mayo Clin Proc Date: 2003-11 Impact factor: 7.616
Authors: Angela Vincent; Camilla Buckley; Jonathan M Schott; Ian Baker; Bonnie-Kate Dewar; Niels Detert; Linda Clover; Abigail Parkinson; Christian G Bien; Salah Omer; Bethan Lang; Martin N Rossor; Jackie Palace Journal: Brain Date: 2004-02-11 Impact factor: 13.501
Authors: Roy Yaari; Susy Favaro; Anna D Burke; Helle Brand; Adam S Fleisher; James D Seward; Jan Dougherty; Pierre N Tariot Journal: Prim Care Companion CNS Disord Date: 2013-06-27